Where this non Hodgkin lymphoma information comes from

All our information is checked by cancer specialists and surgeons who specialise in treating cancer. The names of our specialist reviewers are at the end of this list. We also try to find patients to review all our sections. If you have had non Hodgkin lymphoma, live in the UK and would like to become a patient reviewer, you can write to us by clicking on contact us.

Cancer Research UK
CancerStats Series

US National Cancer Institute
Information on the treatment of non Hodgkin's lymphoma
www.cancer.gov/cancertopics/types/non-hodgkin

Principles and practice of oncology (8th edition) 
De Vita, V T Hellman S and Rosenberg S A 
Lippincott, Williams and Wilkins, 2008

Cancer and its management (6th edition)
Tobias J and Hochhauser D
Wiley-Blackwell 2010

AJCC Cancer Staging Manual (7th edition)
American Joint Committee on Cancer
Springer, 2010

National Institute for Health and Clinical Excellence (NICE) appraisals

Link to the NICE website

Rituximab for the first line treatment of stage 3 or 4 follicular lymphoma
January 2012 (TA243)

Rituximab for the treatment of follicular non Hodgkin's lymphoma (maintenance treatment following response to first-line chemotherapy)
June 2011 (TA226)

Lymphoma (non Hodgkin's) - bendamustine
October 2010 (TA206 - terminated appraisal)

Lymphoma (follicular non Hodgkin's)  ̶̶  rituximab
February 2008 (TA137)

Referral Guidelines for Suspected Cancer
June 2005

Improving Outcomes in Haematological Cancers   ̶̶  The Manual 
October 2003

Non Hodgkin's lymphoma  ̶̶  rituximab
September 2003 (TA65)

The Scottish Government

Scottish referral guidelines for suspected cancer
February 2007

Scottish Medicines Consortium (SMC) advice

Link to the SMC website

Guidance on bendamustine for people who have had rituximab which is no longer working
April 2011 (SMC 701/11)

Rituximab as maintenance therapy for follicular lymphoma
February 2011 (SMC 675/11)

Guidance on rituximab as maintenance therapy for relapsed/refractory follicular lymphoma
December 2006 (SMC 330/06)

Rituximab for stage 3 or 4 follicular lymphoma in combination with CVP chemotherapy
December 2004 (SMC 135/04)

Guidance on rituximab for CD20 positive diffuse large B cell lymphoma
March 2003 (SMC 33/03)

British Committee for Standards in Haematology (BCSH)

Link to the BCSH website

Guidelines for the investigation and management of mantle cell lymphoma (2012)

The investigation and management of follicular lymphoma (2011)

Guidelines for the management of mature T cell lymphoma and NK cell neoplasms (2011)

Non Hodgkin lymphoma. Shankland K, Armitage J, Hancock B et al. (2012) The Lancet. 380:848-57

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow up. Dreyling M, Ghielmini M, Marcus R et al (2011) Annals of Oncology 22 (suppl 6): vi59-63

Gastric Marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow up. Zucca E and Dreyling M. (2010) Annals of Oncology 21 (suppl 5): v175-176

Diffuse large B cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow up. Tilly H and Dreyling M (2010) Annals of Oncology 21 (suppl 5): v172-174

Personal Use of Hair Dyes and Risk of Cancer: a meta analysis. Takkouche B, Etminan M and Montes-Martínez A. (2005) Journal of the American Medical Association. 293(20): 2516-25.

Dr Nilima Parry-Jones, MD, MRCP, MRCPath (Consultant haematologist)
Dr Christopher McNamara, FRACP, FRCPA, FRCPath (Consultant haematologist)

Dee McLean  ̶̶  McDee Art, Medical Illustration